Tessa Gargett Australasian Society for Immunology Annual Scientific Meeting 2014

Abstracts this author is presenting:

• Combination therapy for metastatic melanoma: an investigation of GD2-specific chimeric antigen receptor T cells and MAPK-pathway targeted therapy — Workshop 3: Tumor Immunology